Research Guide · Laboratory Use Only
CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). The version with DAC (Drug Affinity Complex) is studied for its markedly extended half-life via binding to serum albumin.
What it is
CJC-1295 acts at the GHRH receptor on the pituitary to stimulate growth-hormone production. The DAC modification lets it bind albumin, which in research models substantially lengthens how long the peptide remains active compared with native GHRH.
How it’s studied
It is commonly studied alongside GHRP-class secretagogues (such as Ipamorelin) to examine how GHRH-driven and ghrelin-driven pathways combine to shape the GH pulse.
Research focus areas
- GHRH-receptor signaling at the pituitary
- Half-life extension via albumin binding (DAC)
- Synergy models with GHRP-class peptides
- Sustained versus pulsatile GH-release patterns
Handling & documentation
In the laboratory this material is typically supplied as a lyophilized (freeze-dried) powder and reconstituted with bacteriostatic or sterile water for in-vitro work. As with any research compound, the quality signal that matters most is a lot-specific Certificate of Analysis (COA) from an independent lab, confirming identity by mass spectrometry and purity by HPLC. Store per the supplier’s guidance and verify the COA before use.
Browse the COA-verified research catalog →
Leave a Reply